Senior insider sale
CEO and President at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$150.0K
10K shares
What this filing means
STENGONE CARMINE N. plans to sell 10K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $150.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2026ACC: 0001950047-26-006666
DirectorOfficer· CEO and President
Since Feb 2026
10K
Shares to sell
$150.0K
Approx. market value
10K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
6/30/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2026 | Exercise of Stock Options Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10K
Market value
$150.0K
6/30/2026
Total
Units
10K
Value
$150.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/30/2026 | 10K | $150.0K | NASDAQ | Planned |
| Total | 10K | $150.0K | ||